Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies
Relapse is now the major cause of treatment failure after allogeneic HSCT (alloHSCT). Many novel strategies to address this critical issue are now being developed and tested. At the 3rd International Workshop on Biology, Prevention, and Treatment of Relapse held in Hamburg, Germany in November 2016,...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Bone marrow transplantation
Year: 2018, Jahrgang: 54, Heft: 1, Pages: 17-25 |
| ISSN: | 1476-5365 |
| DOI: | 10.1038/s41409-018-0214-5 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1038/s41409-018-0214-5 Verlag, Volltext: https://www.nature.com/articles/s41409-018-0214-5 
|
| Verfasserangaben: | Anna Sureda, Peter Dreger, Michael R. Bishop, Nicolaus Kroger, David L. Porter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1663713359 | ||
| 003 | DE-627 | ||
| 005 | 20220816142523.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190429r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41409-018-0214-5 |2 doi | |
| 035 | |a (DE-627)1663713359 | ||
| 035 | |a (DE-599)KXP1663713359 | ||
| 035 | |a (OCoLC)1341211969 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sureda, Anna |e VerfasserIn |0 (DE-588)116142993X |0 (DE-627)1024721876 |0 (DE-576)506512037 |4 aut | |
| 245 | 1 | 0 | |a Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies |c Anna Sureda, Peter Dreger, Michael R. Bishop, Nicolaus Kroger, David L. Porter |
| 264 | 1 | |c 2019 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 24 May 2018 | ||
| 500 | |a Gesehen am 29.04.2019 | ||
| 520 | |a Relapse is now the major cause of treatment failure after allogeneic HSCT (alloHSCT). Many novel strategies to address this critical issue are now being developed and tested. At the 3rd International Workshop on Biology, Prevention, and Treatment of Relapse held in Hamburg, Germany in November 2016, international experts presented and discussed recent developments in the field. Some approaches may be applicable to a wide range of patients after transplant, whereas some may be very disease-specific. We present a report from the session dedicated to issues related to prevention and treatment of relapse of lymphoid malignancies after alloHSCT. This session included detailed reviews as well as forward-looking commentaries that focused on Hodgkin lymphoma, chronic lymphocytic leukemia and mantle cell lymphoma, diffuse large cell and follicular lymphoma, and multiple myeloma. | ||
| 534 | |c 2018 | ||
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone marrow transplantation |d London : Springer Nature, 1997 |g 54(2019), 1, Seite 17-25 |h Online-Ressource |w (DE-627)320433366 |w (DE-600)2004030-1 |w (DE-576)091012996 |x 1476-5365 |7 nnas |a Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies |
| 773 | 1 | 8 | |g volume:54 |g year:2019 |g number:1 |g pages:17-25 |g extent:9 |a Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41409-018-0214-5 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41409-018-0214-5 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190429 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1663713359 |e 3453658132 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Sureda","role":"aut","display":"Sureda, Anna","given":"Anna"},{"given":"Peter","display":"Dreger, Peter","role":"aut","family":"Dreger"}],"note":["Published: 24 May 2018","Gesehen am 29.04.2019"],"title":[{"title":"Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies","title_sort":"Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies"}],"id":{"eki":["1663713359"],"doi":["10.1038/s41409-018-0214-5"]},"recId":"1663713359","physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Anna Sureda, Peter Dreger, Michael R. Bishop, Nicolaus Kroger, David L. Porter"]},"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"language":["eng"],"relHost":[{"language":["eng"],"pubHistory":["Nachgewiesen 19.1997 -"],"part":{"year":"2019","extent":"9","text":"54(2019), 1, Seite 17-25","issue":"1","volume":"54","pages":"17-25"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 17.01.25"],"title":[{"title_sort":"Bone marrow transplantation","title":"Bone marrow transplantation"}],"id":{"eki":["320433366"],"zdb":["2004030-1"],"issn":["1476-5365"]},"recId":"320433366","physDesc":[{"extent":"Online-Ressource"}],"disp":"Prevention and treatment of relapse after stem cell transplantation in lymphoid malignanciesBone marrow transplantation","origin":[{"publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke ; London","dateIssuedKey":"1997"}]}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a SUREDAANNAPREVENTION2019 | ||